tirzepatide compound lawsuit update US judge denies injunction, restricting copies of Lilly weight-loss drug Your GLP-1 Compound Access Could

I hope, I hope, I hope that one of the companies making a GLP-1 or one of the new incretin-based therapies will do a study in type 1 to show its safe. Hirsch added that careful education about detecting and treating low blood sugar and DKA is key

Blue Cross Blue Shield: Coverage is subject to variability by state and specific plan details, but many plans offer coverage with the requisite prior authorization

Building a routine is about making the process as easy as possible

This week-by-week guide covers what the clinical data and real-world experience tell us about the first 30 days

Concomitant use of ixekizumab (Taltz) and tirzepatide (Zepbound, Eli Lilly) performed better than ixekizumab monotherapy in adults with active psoriatic arthritis (PsA) and obesity or overweight with at least one weight-related condition, according to positive topline results from the novel TOGETHER-PsA open-label Phase 3b trial